Atlas Trials

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Clinical trial NCT05493761 · COMPLETED

Trial details

NCT number
NCT05493761
Sponsor
Aristotle University Of Thessaloniki
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Start date
2022-12-23
Primary completion
2026-07-16
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.